openPR Logo
Press release

PTCA Balloon Catheters Market on position to touch $1,431 Million, Worldwide by 2023

02-18-2019 06:40 PM CET | Health & Medicine

Press release from: Allied Market Research

PTCA Balloon Catheters Market

PTCA Balloon Catheters Market

Percutaneous transluminal coronary angioplasty (PTCA) is a minimally-invasive procedure used to open blocked or narrowed coronary arteries. Use of PTCA balloons provides an effective minimally invasive approach to widen a narrowed coronary artery. During the procedure, an empty balloon (balloon catheter) is passed into narrow arteries with the help of a wire (generally a catheter). Once the balloon reaches the desired position, it is inflated. This results into the displacement of stenosis (narrowing) from the vessel wall. The balloon is removed after the procedure. PTCA is generally followed by stent placement, but is not mandatory.

Global PTCA Balloon Catheters Market was valued at $1,064 million in 2016, and is expected to reach $1,431 million by 2023, growing at a CAGR of 4.3% from 2017 to 2023.

Request Sample/ TOC Report @ https://www.alliedmarketresearch.com/request-sample/2635

The normal balloon catheter segment is expected to maintain its dominant position during the analysis period, owing to reduced complications associated with them when compared to other product types. The drug eluting balloon catheter segment is expected to grow at a rapid CAGR of 4.7% throughout the forecast period.

There has been an increased use of drug-eluting balloons in the past few years. The use of drug-eluting balloons has resulted in the reduction in the use of vessel implants (such as stents), which may cause vessel fracture. In addition, drug-eluting balloons are safe and they provide the highest rate of restoration of normal blood flow when compared to other balloon catheters.

Increase in ageing population and changes in lifestyle leading to hypertension, obesity, and other risk factors that lead to vascular disorders is expected to propel the growth of the PTCA balloon catheters market. In addition, technological advancements and reclassification of some PTCA catheters from class III to class II device by FDA, and increase in prevalence of cardiovascular disorders are expected to further drive the market growth. However, availability of alternative therapies, and complications associated with PTCA balloon catheters restrain this growth. The upsurge in demand for minimally invasive surgeries, rise in disposable incomes, and growth prospects in emerging economies of Asia-Pacific and LAMEA are expected to provide numerous opportunities for market growth during the forecast period.

Key Findings of the PTCA Balloon Catheters Market:

• Polyolefin copolymer (POC) accounted for more than half of the materials segment in 2016
• The RX balloon catheter segment accounted for more than four-fifths of the global market in 2016
• Drug eluting balloon catheter is expected to grow at the highest CAGR of 4.7% from 2017 to 2023
• The semi-compliant segment accounted for four-fifths of the global market in 2016
• Asia-Pacific is expected to grow at the highest CAGR of 5.7%, from 2017 to 2023

North America accounted for more than two-fifths of the global market in 2016, and is expected to remain dominant throughout the forecast period. This is attributed to the increase in incidence of cardiovascular diseases; growth in geriatric population; and changing lifestyle of people that leads to cardiac abnormalities. In addition, high adoption rate of technologically advanced devices and presence of highly sophisticated healthcare infrastructure are expected to present new growth opportunities to the players in this market.

Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/2635

The major companies profiled in the report include The list of key players profiled in this report include Abbott Laboratories, B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc., Medtronic plc, MicroPort Scientific Corporation, Terumo Corporation, and THE SPECTRANETICS CORPORATION.

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release PTCA Balloon Catheters Market on position to touch $1,431 Million, Worldwide by 2023 here

News-ID: 1597169 • Views: 280

More Releases from Allied Market Research

Bioburden Testing Market 2020: Increasing Demand for Efficient Management Practi …
Growth in the medical devices, pharmaceutical and rising product recalls due to microbial contamination are factors that drive the growth of the world bioburden testing market. In addition, biotechnology industries and increasing food & beverage safety concerns supplements growth. However, high cost of microbial enumeration instruments obstructs the growth of the market. Increasing preference for contract manufacturing and emerging economies are creating opportunities in the market. Download Free Sample Report@ https://www.alliedmarketresearch.com/request-sample/928 Bioburden
Epoxy Resin Market From 2020-2027: Growth Analysis by Manufacturers | Dow Chemic …
Development of end-use industries, surge in demand for lightweight composites, and increase in R&D activities in the epoxy resin technology have boosted the growth of the global epoxy resin market. However, fluctuation in raw material prices hampers the market. On the contrary, advent of bio-based epoxy resin is expected to create new opportunities for the market players in the coming years. As per the research published by Allied Market Research, the
Allergy Diagnostic Market Size, Top Key Players, Latest Trends, Regional Insight …
Allergy is an exaggerated response of immune systems, which causes skin irritation, hay-fever, asthma, anaphylaxis and other symptoms. Therefore, it needs to be diagnosed and treated properly. In order to detect an allergy, skin tests and blood tests are performed by the healthcare providers. Rapidly increasing allergy incidences and changes in dietary habits are the major factors driving the growth of allergy diagnostics market. Furthermore, increasing environmental pollution, favourable reimbursements
Cell Counting Market Size, Top Key Players, Latest Trends, Regional Insights and …
Cell counting is a method of counting cells for medical applications, and plays an important role in research and clinical activities. Cell counts in liquid media is expressed in cells per unit of volume or concentration. Numerous treatment procedures necessitate cell counting to carry out further procedures. For instance, the concentration of red blood cells or while blood cells provide vital information about the condition of health of a patient.

All 5 Releases


More Releases for PTCA

PTCA Balloon Catheters Market Value Expected to Show $1,431 Million by 2023 : Al …
"There has been an increased use of drug-eluting balloons in the past few years. The use of drug-eluting balloons has resulted in the reduction in the use of vessel implants (such as stents), which may cause vessel fracture. In addition, drug-eluting balloons are safe and they provide the highest rate of restoration of normal blood flow when compared to other balloon catheters.‐ She further added that ‐reclassification of some of
PTCA Balloon Catheter Market Report Explored in Latest Research 2015 to 2021
Percutaneous transluminal coronary angioplasty (PTCA) refers to a minimally-invasive procedure for opening blocked or narrowed coronary arteries caused by coronary arteries disease (CAD). PTCA balloon catheters help to allow the blood to flow from the arteries to the heart muscles without the need for open heart surgery. Coronary heart disease is caused by smoking, high blood pressure, diabetes, and a high level of cholesterol in the blood. Some of the
Ptca Balloon Catheter Market Forecast By 2021
Percutaneous transluminal coronary angioplasty (PTCA) refers to a minimally-invasive procedure for opening blocked or narrowed coronary arteries caused by coronary arteries disease (CAD). PTCA balloon catheters help to allow the blood to flow from the arteries to the heart muscles without the need for open heart surgery. Coronary heart disease is caused by smoking, high blood pressure, diabetes, and a high level of cholesterol in the blood. Some of the
Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market 20 …
Apex Apex Market Reports, recently published a detailed market research study focused on the "Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market" across the global, regional and country level. The report provides 360° analysis of "Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Percutaneous Transluminal Coronary
Global and China PTCA Balloon Catheter Research Report to 2021
This report studies PTCA Balloon Catheter in Global and China market, focuses on top manufacturers in global and China market, involving PTCA Balloon Catheter price of each type, production, revenue and market share for each manufacturer. This report also displays the production, revenue and market share of PTCA Balloon Catheter in USA, EU, China, Japan, India and Southeast Asia, forecast to 2020, from 2011. Split by product types, with production, revenue,
Global PTCA Balloon Catheter Market to Witness Exponential Growth by 2021
Percutaneous transluminal coronary angioplasty (PTCA) refers to a minimally-invasive procedure for opening blocked or narrowed coronary arteries caused by coronary arteries disease (CAD). PTCA balloon catheters help to allow the blood to flow from the arteries to the heart muscles without the need for open heart surgery. Coronary heart disease is caused by smoking, high blood pressure, diabetes, and a high level of cholesterol in the blood. Some of the